Paraza Pharma, a Canada-based, fully integrated drug discovery organisation, announced on Monday that it has named Dr Chudi Ndubaku as its new chief scientific officer.

In the new role, Dr Ndubaku is to head and drive the strategic growth of the company's R&D division, with unitary focus to further improve the scientific impact of Paraza research on client-partners' programs.

Dr Ndubaku has held various senior scientific leadership positions at Genentech, Aduro Biotech and ORIC Pharmaceuticals.